Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 286

1.

Serologic cross-reactivity of human IgM and IgG antibodies to five species of Ebola virus.

Macneil A, Reed Z, Rollin PE.

PLoS Negl Trop Dis. 2011 Jun;5(6):e1175. doi: 10.1371/journal.pntd.0001175. Epub 2011 Jun 7.

2.

Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995.

Ksiazek TG, Rollin PE, Williams AJ, Bressler DS, Martin ML, Swanepoel R, Burt FJ, Leman PA, Khan AS, Rowe AK, Mukunu R, Sanchez A, Peters CJ.

J Infect Dis. 1999 Feb;179 Suppl 1:S177-87.

PMID:
9988182
3.

ELISA for the detection of antibodies to Ebola viruses.

Ksiazek TG, West CP, Rollin PE, Jahrling PB, Peters CJ.

J Infect Dis. 1999 Feb;179 Suppl 1:S192-8.

PMID:
9988184
4.

Prevalence of IgG antibodies to Ebola virus in individuals during an Ebola outbreak, Democratic Republic of the Congo, 1995.

Busico KM, Marshall KL, Ksiazek TG, Roels TH, Fleerackers Y, Feldmann H, Khan AS, Peters CJ.

J Infect Dis. 1999 Feb;179 Suppl 1:S102-7.

PMID:
9988172
5.

Profiling the native specific human humoral immune response to Sudan Ebola virus strain Gulu by chemiluminescence enzyme-linked immunosorbent assay.

Sobarzo A, Perelman E, Groseth A, Dolnik O, Becker S, Lutwama JJ, Dye JM, Yavelsky V, Lobel L, Marks RS.

Clin Vaccine Immunol. 2012 Nov;19(11):1844-52. doi: 10.1128/CVI.00363-12. Epub 2012 Sep 19.

6.

Immune memory to Sudan virus: comparison between two separate disease outbreaks.

Sobarzo A, Eskira Y, Herbert AS, Kuehne AI, Stonier SW, Ochayon DE, Fedida-Metula S, Balinandi S, Kislev Y, Tali N, Lewis EC, Lutwama JJ, Dye JM, Yavelsky V, Lobel L.

Viruses. 2015 Jan 6;7(1):37-51. doi: 10.3390/v7010037.

7.

Isolated case of Ebola hemorrhagic fever with mucormycosis complications, Kinshasa, Democratic Republic of the Congo.

Kalongi Y, Mwanza K, Tshisuaka M, Lusiama N, Ntando E, Kanzake L, Shieh WJ, Zaki SR, Lloyd ES, Ksiazek TG, Rollin PE.

J Infect Dis. 1999 Feb;179 Suppl 1:S15-7.

PMID:
9988159
8.

Specific neutralizing response in plasma from convalescent patients of Ebola Virus Disease against the West Africa Makona variant of Ebola virus.

Luczkowiak J, Arribas JR, Gómez S, Jiménez-Yuste V, de la Calle F, Viejo A, Delgado R.

Virus Res. 2016 Feb 2;213:224-229. doi: 10.1016/j.virusres.2015.12.019. Epub 2015 Dec 29.

PMID:
26739425
10.

Development of Prototype Filovirus Recombinant Antigen Immunoassays.

Boisen ML, Oottamasathien D, Jones AB, Millett MM, Nelson DS, Bornholdt ZA, Fusco ML, Abelson DM, Oda S, Hartnett JN, Rowland MM, Heinrich ML, Akdag M, Goba A, Momoh M, Fullah M, Baimba F, Gbakie M, Safa S, Fonnie R, Kanneh L, Cross RW, Geisbert JB, Geisbert TW, Kulakosky PC, Grant DS, Shaffer JG, Schieffelin JS, Wilson RB, Saphire EO, Branco LM, Garry RF, Khan SH, Pitts KR; Viral Hemorrhagic Fever Consortium.

J Infect Dis. 2015 Oct 1;212 Suppl 2:S359-67. doi: 10.1093/infdis/jiv353. Epub 2015 Jul 30.

11.

High prevalence of IgG antibodies to Ebola virus in the Efé pygmy population in the Watsa region, Democratic Republic of the Congo.

Mulangu S, Borchert M, Paweska J, Tshomba A, Afounde A, Kulidri A, Swanepoel R, Muyembe-Tamfum JJ, Van der Stuyft P.

BMC Infect Dis. 2016 Jun 10;16:263. doi: 10.1186/s12879-016-1607-y.

12.

Evaluation of recombinant dengue viral envelope B domain protein antigens for the detection of dengue complex-specific antibodies.

Simmons M, Porter KR, Escamilla J, Graham R, Watts DM, Eckels KH, Hayes CG.

Am J Trop Med Hyg. 1998 Feb;58(2):144-51.

PMID:
9502595
13.

Serological evidence of Ebola virus infection in Indonesian orangutans.

Nidom CA, Nakayama E, Nidom RV, Alamudi MY, Daulay S, Dharmayanti IN, Dachlan YP, Amin M, Igarashi M, Miyamoto H, Yoshida R, Takada A.

PLoS One. 2012;7(7):e40740. doi: 10.1371/journal.pone.0040740. Epub 2012 Jul 18.

14.

Development of a Sensitive and Specific Serological Assay Based on Luminex Technology for Detection of Antibodies to Zaire Ebola Virus.

Ayouba A, Touré A, Butel C, Keita AK, Binetruy F, Sow MS, Foulongne V, Delaporte E, Peeters M.

J Clin Microbiol. 2016 Dec 28;55(1):165-176. doi: 10.1128/JCM.01979-16. Print 2017 Jan.

15.

Enzyme-linked immunosorbent assay for detection of filovirus species-specific antibodies.

Nakayama E, Yokoyama A, Miyamoto H, Igarashi M, Kishida N, Matsuno K, Marzi A, Feldmann H, Ito K, Saijo M, Takada A.

Clin Vaccine Immunol. 2010 Nov;17(11):1723-8. doi: 10.1128/CVI.00170-10. Epub 2010 Sep 22.

16.

[Investigation of dengue virus and yellow fever virus seropositivities in blood donors from Central/Northern Anatolia, Turkey].

Ergünay K, Saygan MB, Aydoğan S, Litzba N, Niedrig M, Pınar A, Us D.

Mikrobiyol Bul. 2010 Jul;44(3):415-24. Turkish.

PMID:
21063991
17.

Human asymptomatic Ebola infection and strong inflammatory response.

Leroy EM, Baize S, Volchkov VE, Fisher-Hoch SP, Georges-Courbot MC, Lansoud-Soukate J, Capron M, Debré P, McCormick JB, Georges AJ.

Lancet. 2000 Jun 24;355(9222):2210-5.

PMID:
10881895
18.

Serologic survey among hospital and health center workers during the Ebola hemorrhagic fever outbreak in Kikwit, Democratic Republic of the Congo, 1995.

Tomori O, Bertolli J, Rollin PE, Fleerackers Y, Guimard Y, De Roo A, Feldmann H, Burt F, Swanepoel R, Killian S, Khan AS, Tshioko K, Bwaka M, Ndambe R, Peters CJ, Ksiazek TG.

J Infect Dis. 1999 Feb;179 Suppl 1:S98-101.

PMID:
9988171
19.

Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidémies à Kikwit.

Rowe AK, Bertolli J, Khan AS, Mukunu R, Muyembe-Tamfum JJ, Bressler D, Williams AJ, Peters CJ, Rodriguez L, Feldmann H, Nichol ST, Rollin PE, Ksiazek TG.

J Infect Dis. 1999 Feb;179 Suppl 1:S28-35.

PMID:
9988162
20.

Evaluation of immunoglobulin M (IgM) and IgG enzyme immunoassays in serologic diagnosis of West Nile Virus infection.

Tardei G, Ruta S, Chitu V, Rossi C, Tsai TF, Cernescu C.

J Clin Microbiol. 2000 Jun;38(6):2232-9.

Supplemental Content

Support Center